Author:
Simeone Jason C.,Nordstrom Beth L.,Appenteng Kwame,Huse Samuel,D’Silva Milbhor
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Chen GD, Lin TL, Hu SW, et al. Prevalence and correlation of urinary incontinence and overactive bladder in Taiwanese women. Neurourol Urodyn. 2003;22(2):109–17.
https://doi.org/10.1002/nau.10010
.
2. Cheung WW, Blank W, Borawski D, et al. Prevalence of overactive bladder, its under-diagnosis, and risk factors in a male urologic veterans population. Int J Med Sci. 2010;7(6):391–4.
3. Cheung WW, Khan NH, Choi KK, et al. Prevalence, evaluation and management of overactive bladder in primary care. BMC Fam Pract. 2009;10:8.
https://doi.org/10.1186/1471-2296-10-8
.
4. Corcos J, Schick E. Prevalence of overactive bladder and incontinence in Canada. Can J Urol. 2004;11(3):2278–84.
5. Astellas Pharma US Inc. Myrbetriq® Full Prescribing Information. Astellas Pharma US, Inc., Northbrook, Illinois. Revised: 8/2016.
https://www.us.astellas.com/docs/Myrbetriq_WPI.pdf
. Accessed 28 Feb 2017.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献